EDMONTON, AB, March 20, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to announce the Company's discovery of ...

(RTTNews) - Aurora Cannabis Inc. (ACB.TO), a medical cannabis company based in Canada, Thursday has announced the discovery of a novel genetic resistance source against powdery mildew, known as PM2.

Aurora Cannabis ( (TSE:ACB)) has issued an update. On January 14, 2026, Aurora Cannabis announced that it has made significant progress in its research into powdery mildew resistance, nearly a year ...

There's no universally superior option here. Seeds reward patience, offer genetic flexibility, and reduce disease risk on entry.